Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barbui

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
The Cochrane Database of Systematic Reviews|June 14, 2003
Amitriptyline versus other types of pharmacotherapy for depressionG Guaiana, C Barbui, M Hotopf
The Cochrane Database of Systematic Reviews|August 15, 2003
Low dosage tricyclic antidepressants for depressionT Furukawa, H McGuire, C Barbui
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 16, 1998
Clozapine and blood dyscrasias different from agranulocytosisC Barbui, A Campomori, M Bonati
Epidemiology and Psychiatric Sciences|July 7, 2015
Access to mental health services and psychotropic drug use in refugees and asylum seekers hosted in high-income countriesM Nosè, G Turrini, C Barbui
Epidemiology and Psychiatric Sciences|January 12, 2018
Public health psychopharmacology: a new research discipline comes of age?C Barbui, G Ostuzzi, B Godman
Psychological Medicine|October 29, 2003
How often do patients with psychosis fail to adhere to treatment programmes? A systematic reviewM Nosé, C Barbui, M Tansella
Experimental Nephrology|March 1, 1993
Studies of privileged sites and organ transplantationN Perico, C Barbui, G Remuzzi
Evidence-Based Mental Health|January 29, 2008
Review: atypical antipsychotics are effective adjuncts for treatment resistant depression but increase discontinuation due to adverse effectsA Cipriani, M Dieterich, C Barbui
European Psychiatry : the Journal of the Association of European Psychiatrists|August 22, 2000
Does placebo help establish equivalence in trials of new antidepressants?C Barbui, A Violante, S Garattini
Journal of Clinical Psychopharmacology|January 5, 2002
Regulatory issues in EuropeC Barbui, G Guaiana, S Garattini
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
The Cochrane Database of Systematic Reviews|June 14, 2003
Amitriptyline versus other types of pharmacotherapy for depressionG Guaiana, C Barbui, M Hotopf
The Cochrane Database of Systematic Reviews|August 15, 2003
Low dosage tricyclic antidepressants for depressionT Furukawa, H McGuire, C Barbui
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 16, 1998
Clozapine and blood dyscrasias different from agranulocytosisC Barbui, A Campomori, M Bonati
Epidemiology and Psychiatric Sciences|July 7, 2015
Access to mental health services and psychotropic drug use in refugees and asylum seekers hosted in high-income countriesM Nosè, G Turrini, C Barbui
Epidemiology and Psychiatric Sciences|January 12, 2018
Public health psychopharmacology: a new research discipline comes of age?C Barbui, G Ostuzzi, B Godman
Psychological Medicine|October 29, 2003
How often do patients with psychosis fail to adhere to treatment programmes? A systematic reviewM Nosé, C Barbui, M Tansella
Experimental Nephrology|March 1, 1993
Studies of privileged sites and organ transplantationN Perico, C Barbui, G Remuzzi
Evidence-Based Mental Health|January 29, 2008
Review: atypical antipsychotics are effective adjuncts for treatment resistant depression but increase discontinuation due to adverse effectsA Cipriani, M Dieterich, C Barbui
European Psychiatry : the Journal of the Association of European Psychiatrists|August 22, 2000
Does placebo help establish equivalence in trials of new antidepressants?C Barbui, A Violante, S Garattini
Journal of Clinical Psychopharmacology|January 5, 2002
Regulatory issues in EuropeC Barbui, G Guaiana, S Garattini
Pageof 11